Scope
Reference
DACPM2025-25
Description
Procurement of (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
Contract 1. (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
Supplier
Contract value
- £2,600,000 excluding VAT
- £2,600,000 including VAT
Above the relevant threshold
Award decision date
21 May 2025
Standstill period
- End: 2 June 2025
- 8 working days
Earliest date the contract will be signed
16 June 2025
Contract dates (estimated)
- 17 June 2025 to 30 June 2027
- 2 years, 14 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
CHIESI LIMITED
- Companies House: 02140985
- Public Procurement Organisation Number: PDRG-6355-YCVG
333 Styal Road
Manchester
M22 5LG
United Kingdom
Email: CustomerServices.UK@chiesi.com
Website: https://www.chiesi.uk.com/
Region: UKD33 - Manchester
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. (ULM) ELAPEGADEMASE (REVCOVI) 2.4 MG/1.5 ML SOLUTION FOR INJECTION, 1 vial
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland